Estimaciones de analistas de Wall Street para Protalix BioTherapeutics, Inc. (PLX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 5 |
| Mantener | 2 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 7 |
| Calificación media (1-5) | 0.71 |
Ratios de valoración
| Ratio P/E | 11.12 |
| Precio / Valor contable | 3.00 |
| EV / EBITDA | 7.49 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $9.2M | $21.1M | $34.2M | $54.7M | $62.9M | $38.4M | $47.6M | $65.5M | $53.4M | $52.7M |
| Coste de Ventas | $8.4M | $15.2M | $9.3M | $10.9M | $10.9M | $16.3M | $19.6M | $23.0M | $24.3M | $27.5M |
| Beneficio Bruto | $801000 | $5.8M | $24.9M | $43.8M | $52.0M | $22.0M | $28.0M | $42.5M | $29.1M | $25.2M |
| I+D | $30.4M | $28.8M | $33.3M | $44.6M | $38.2M | $29.7M | $29.3M | $17.1M | $13.0M | $19.1M |
| Generales y Administrativos | $9.4M | $11.5M | $10.9M | $9.9M | $11.1M | $12.7M | $11.7M | $15.0M | $12.2M | $11.7M |
| Gastos Operativos | $34.0M | $40.4M | $44.2M | $54.5M | $49.3M | $42.5M | $41.1M | $32.1M | $25.2M | $30.7M |
| Beneficio Operativo | -$33.2M | -$34.5M | -$19.3M | -$10.7M | $2.7M | -$20.5M | -$13.0M | $10.5M | $3.9M | -$5.5M |
| EBITDA | -$23.0M | -$71.8M | -$17.1M | -$8.7M | $4.5M | -$18.9M | -$10.8M | $12.9M | $6.5M | -$3.0M |
| Gastos por Intereses | $4.2M | $9.7M | $7.7M | $8.0M | $9.7M | $7.5M | $2.5M | $3.2M | $1.1M | $1.2M |
| Beneficio Antes de Impuestos | -$29.2M | -$83.4M | -$26.5M | -$18.3M | -$6.5M | -$27.6M | -$14.4M | $8.6M | $4.2M | -$5.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | $530000 | $254000 | $1.2M | $996000 |
| Beneficio Neto | -$29.4M | -$83.4M | -$26.5M | -$18.3M | -$6.5M | -$27.6M | -$14.9M | $8.3M | $2.9M | -$6.6M |
| BPA | $-0.29 | $-6.50 | $-1.80 | $-1.23 | $-0.22 | $-0.62 | $-0.31 | $0.12 | $0.04 | $-0.08 |
| BPA Diluido | $-0.29 | $-6.50 | $-1.80 | $-1.23 | $-0.22 | $-0.62 | $-0.31 | $0.10 | $0.04 | $-0.08 |
| Acciones en Circulación (Diluidas) | $101.4M | $13.1M | $14.7M | $14.8M | $29.1M | $44.1M | $48.5M | $82.4M | $81.1M | $78.5M |
Precio
| Precio | $2.68 |
| Capitalización | $216M |
| Bolsa | AMEX |
| País | US |
Empresas relacionadas: CDXS · CHRS · GNFT · IVVD · MDWD · NTHI · OABI
Explorar sector: Healthcare · Biotechnology
Más secciones de PLX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones